One in every five people worldwide will have developed some form
of skin cancer within his lifetime.
Over 70 Million people will be screened annually for the detection of
skin cancer.More than 11 million people will be diagnosed as having
developed some form of skin cancer.
70,000 mortalities annually as a result of skin cancer, of them 60,000
Over 4 Billion USD annually expended worldwide on unnecessary
biopsies for skin cancer diagnostics.
These facts pertain only to those who are aware enough and have
access to screening for detection of skin cancer.
S.C.S. was formed with the aim of developing a medical system for
the early and accurate diagnosis of skin cancer, thus filling this gap.
All of S.C.S.’s human and financial resources are dedicated to this goal.
Save human lives and improve life quality and expectancy by
introducing advanced, easily accessible, friendly diagnostic systems
for the early diagnosis of skin cancer.
Promote the system as a leading and meaningful component in the
skin cancer field, by joining an active major corporation in the medical
Our system is based on advanced technology using a unique
innovative method of data accumulation and signal processing in the
Visual and Infrared spectrum.
The system is passive and non invasive.
The I.P. is in the patent pending stage in the USA and national patent
registration according to PCT.
The system is undergoing clinical trials with excellent results.